Pulse Biosciences, Inc (PLSE) Dividend History

Pulse Biosciences, Inc. is a biotechnology company that develops innovative medical technologies based on its proprietary Nano-Pulse Stimulation (NPS) platform. The company focuses on creating minimally invasive, targeted treatments for a range of medical conditions, including dermatological and oncological applications. By utilizing high-frequency electrical pulses, Pulse Biosciences aims to provide precise and effective therapies with reduced patient recovery times.

3957 Point Eden Way, Hayward, CA, 94545
Phone: 510-906-4600
Website: https://www.pulsebiosciences.com

Dividend History

Pulse Biosciences, Inc currently does not pay dividends

Company News

  • Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday

    With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. (NYSE: PVH) to report quarterly earnings at $3.52 per share on revenue of $2.42 billion after the closing bell, according to data from Benzinga Pro. PVH shares gained 0.3% to $141.00 in after-hours trading. Oxford Industries, Inc. (NYSE: OXM) reported downbeat financial results ...

    Benzinga
    Featured Companies: CURV NGS OXM PVH
  • Hot Penny Stocks To Watch As The Stock Market Crash Continues

    Hot penny stocks to add to your watch list this week. Is it time to buy? The post Hot Penny Stocks To Watch As The Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: LVTX PFE SPRO TCRT
  • Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates

    Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: NPCE
  • Why Pulse Biosciences Stock Moved Higher Thursday

    The medical technology company got rid of $41.6 million in debt with a large private sale of stock on Thursday.

    The Motley Fool
Page data last updated 07/23/2025 16:25:43 UTC